Stock BAX BAXTER INTERNATIONAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Baxter International Inc.

Equities

BAX

US0718131099

Market Closed - Nyse
Other stock markets
 16:00:02 2024-05-03 EDT 		5-day change 1st Jan Change
36.89 USD -0.05% Intraday chart for Baxter International Inc. -8.30% -4.58%
05-03 UBS Adjusts Price Target on Baxter International to $40 From $42, Maintains Neutral Rating MT
05-03 Evercore ISI Adjusts Price Target on Baxter International to $46 From $50 MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Baxter International Q1 Adjusted Earnings, Net Sales Gain; Boosts 2024 Adjusted Profit Guidance
Baxter International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Baxter International Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024
WOCHENVORSCHAU: Termine bis 10. Mai 2024
Edwards Lifesciences Corporation: het verhaal gaat verder
Edwards Lifesciences Corporation : La historia continúa
Edwards Lifesciences Corporation: Fortlaufende Erfolgsgeschichte
Edwards Lifesciences Corporation: la storia continua
Edwards Lifesciences Corporation : L’histoire se poursuit
Baxter International Inc. Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period
Baxter International Receives US FDA Clearance for Novum IQ Large Volume Infusion Pump
Baxter International Inc. Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
Baxter International Receives a Shareholder Proposal from John Chevedden
Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data
Baxter International Now Considering Sale of Kidney Care Business to Private Equity Investors
Dialysis firms gain as Ozempic kidney trial data disappoints
Baxter International Provides an Update on the Planned Separation of its Kidney Care Business
Baxter International Inc. Declares Quarterly Dividend, Payable on April 1, 2024
Correction: Baxter International's Q4 Adjusted Earnings, Revenue Rise; Issues Q1, 2024 Earnings Forecasts
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAX Stock
  4. News Baxter International Inc.
  5. Other languages